Fig. 3From: The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?MLE fits as a function of age to (a) intensity data for S. haematobium (data from Misungwi area (Tanzania) [25]) and (b) prevalence data (data from Msambweni area (Kenya) [18])Back to article page